研究成果

點擊數: 1246

 

申   請   案：118案（2013年-2024年6月）

論          文：45篇（2013年-2024年）

專利與季轉：0件

論文發表清單

2013

  1. Wang HC, Chiang WF, Huang HH, Huang SK, Chiang HC. Promoter hypermethylation of the gene encoding heat shock protein B1 in oral squamous carcinoma cells. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Mar;115(3):376-84. (CMBEC-102-001)

2014

  1. Wu CC, Chang YT, Chang KP, Liu YL, Liu HP, Lee IL, Yu JS, Chiang WF. Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1569-78. (CMBEC-103-004)

2015

  1. Takata K, Hong ME, Sitthinamsuwan P, Loong F, Tan SY, Liau JY, Hsieh PP, Ng SB, Yang SF, Pongpruttipan T, Sukpanichnant S, Kwong YL, Hyeh Ko Y, Cho YT, Chng WJ, Matsushita T, Yoshino T, Chuang SS. Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia. Am J Surg Pathol. 2015 Jan;39(1):1-12. (CMBEC-103-002)
  2. Jhuang JY, Chang ST, Weng SF, Pan ST, Chu PY, Hsieh PP, Wei CH, Chou SC, Koo CL, Chen CJ, Hsu JD, Chuang SS. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors. Hum Pathol. 2015 Feb;46(2):313-21. (CMBEC-103-002)
  3. Hung CC, Chien CY, Chiang WF, Lin CS, Hour TC, Chen HR, Wang LF, Ko JY, Chang CH, Chen JY. p22phox confers resistance to cisplatin, by blocking its entry into the nucleus. Oncotarget. 2015 Feb 28;6(6):4110-25. (CMBEC-104-004, CMBEC-104-011, CMBEC-104-012)

2016

  1. Feng YH, Chen WY, Kuo YH, Tung CL, Tsao CJ, Shiau AL, Wu CL. Elovl6 is a poor prognostic predictor in breast cancer. Oncol Lett. 2016 Jul;12(1):207-212. (CMBEC-103-010)
  2. Yu JS, Chen YT, Chiang WF, Hsiao YC, Chu LJ, See LC, Wu CS, Tu HT, Chen HW, Chen CC, Liao WC, Chang YT, Wu CC, Lin CY, Liu SY, Chiou ST, Chia SL, Chang KP, Chien CY, Chang SW, Chang CJ, Young JD, Pao CC, Chang YS, Hartwell LH. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan. Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11549-11554. (CMBEC-103-004)

2017

  1. Chen YT, Chen HW, Wu CF, Chu LJ, Chiang WF, Wu CC, Yu JS, Tsai CH, Liang KH, Chang YS, Wu M, Ou Yang WT. Development of a Multiplexed Liquid Chromatography Multiple-Reaction-Monitoring Mass Spectrometry (LC-MRM/MS) Method for Evaluation of Salivary Proteins as Oral Cancer Biomarkers. Mol Cell Proteomics. 2017 May;16(5):799-811. (CMBEC-103-004)
  2. Chen TW, Lee CC, Liu H, Wu CS, Pickering CR, Huang PJ, Wang J, Chang IY, Yeh YM, Chen CD, Li HP, Luo JD, Tan BC, Chan TEH, Hsueh C, Chu LJ, Chen YT, Zhang B, Yang CY, Wu CC, Hsu CW, See LC, Tang P, Yu JS, Liao WC, Chiang WF, Rodriguez H, Myers JN, Chang KP, Chang YS. APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism. Nat Commun. 2017 Sep 6;8(1):465. (CMBEC-103-004)
  3. Hsiao YC, Chi LM, Chien KY, Chiang WF, Chen SF, Chuang YN, Lin SY, Wu CC, Chang YT, Chu LJ, Chen YT, Chia SL, Chien CY, Chang KP, Chang YS, Yu JS. Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry. Mol Cell Proteomics. 2017 Oct;16(10):1829-1849. (CMBEC-103-004)
  4. Li HY, Liang JL, Kuo YL, Lee HH, Calkins MJ, Chang HT, Lin FC, Chen YC, Hsu TI, Hsiao M, Ger LP, Lu PJ. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer. Breast Cancer Res. 2017 Dec 19;19(1):133. (CMBEC-104-015)

2018

  1. Chiang WF, Cheng TM, Chang CC, Pan SH, Changou CA, Chang TH, Lee KH, Wu SY, Chen YF, Chuang KH, Shieh DB, Chen YL, Tu CC, Tsui WL, Wu MH. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation. Oncogene. 2018 Jan 4;37(1):116-127. (CMBEC-104-010)
  2. Su YC, Feng YH, Wu HT, Huang YS, Tung CL, Wu P, Chang CJ, Shiau AL, Wu CL. Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression. Sci Rep. 2018 Apr 26;8(1):6586. (CMBEC-103-010)
  3. He HL, Lee YE, Chang MT, Shiue YL, Chang SL, Chen TJ, Chiu CT. AMACR overexpression acts as a negative prognostic factor in oral squamous cell carcinoma. Int J Med Sci. 2018 Apr 3;15(6):638-644. (CMBEC-107-011)
  4. Wu MH, Luo JD, Wang WC, Chang TH, Hwang WL, Lee KH, Liu SY, Yang JW, Chiou CT, Chang CH, Chiang WF. Risk analysis of malignant potential of oral verrucous hyperplasia: A follow-up study of 269 patients and copy number variation analysis. Head Neck. 2018 May;40(5):1046-1056. (CMBEC-104-016, CMBEC-106-003)
  5. Chen BJ, Wang RC, Ho CH, Yuan CT, Huang WT, Yang SF, Hsieh PP, Yung YC, Lin SY, Hsu CF, Su YZ, Kuo CC, Chuang SS. Primary effusion lymphoma in Taiwan shows two distinctive clinicopathological subtypes with rare human immunodeficiency virus association. Histopathology. 2018 May;72(6):930-944. (CMBEC-107-002)
  6. 王傑田, 范美玲, 盧納密. 基因蛋白p63（TAp63）和p40（ΔNp63）的表現在乳癌分類診斷之研究. 台灣醫檢雜誌. 2018 33卷4期:1-7.

2019

  1. Pan ST, Wang RC, Kuo CC, Hsieh YC, Su YZ, Chuang SS. MYD88 L265P mutation analysis is a useful diagnostic adjunct for lymphoplasmacytic lymphoma with pleural effusion. Pathol Int. 2019 Oct;69(10):601-607. (CMBEC-108-005)
  2. Feng YH, Tung CL, Su YC, Tsao CJ, Wu TF. Proteomic Profile of Sorafenib Resistance in Hepatocellular Carcinoma; GRP78 Expression Is Associated With Inferior Response to Sorafenib. Cancer Genomics Proteomics. 2019 Nov-Dec;16(6):569-576. (CMBEC-103-010)

2020

  1. Chi LM, Hsiao YC, Chien KY, Chen SF, Chuang YN, Lin SY, Wang WS, Chang IY, Yang C, Chu LJ, Chiang WF, Chien CY, Chang YS, Chang KP, Yu JS. Assessment of candidate biomarkers in paired saliva and plasma samples from oral cancer patients by targeted mass spectrometry. J Proteomics. 2020 Jan 16;211:103571. (CMBEC-103-004)
  2. Hsu WL, Tsai MH, Wu CY, Liang JL, Lu JH, Kahle JS, Yu HS, Yen CJ, Yen CT, Hsieh YC, Huang YY, Lin LC, Tsai TF, Chen CH, Yoshioka T. Nociceptive transient receptor potential canonical 7 (TRPC7) mediates aging-associated tumorigenesis induced by ultraviolet B. Aging Cell. 2020 Jan;19(1):e13075. (CMBEC-105-001)
  3. Chen JJ, Tung HD, Lee PL, Kuo HT, Sheu MJ, Cheng CT, Chuang TW, Kao HJ, Lu NM, Wu LC, Lee C. High prevalence of genotype 6 hepatitis C virus infection in Southern Taiwan using Abbott genotype assays. J Formos Med Assoc. 2020 Jan;119(1 Pt 3):413-419. (CMBEC-109-001)
  4. Hsiao YC, Lin SY, Chien KY, Chen SF, Wu CC, Chang YT, Chi LM, Chu LJ, Chiang WF, Chien CY, Chang KP, Chang YS, Yu JS. An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samples. Anal Chim Acta. 2020 Mar 1;1100:118-130. (CMBEC-103-004)
  5. Wu CY, Wang RC, Chen BJ, Chen WY, Jhuang JY, Chang MC, Wu YH, Nakada N, Karube K, Chuang SS. Granuloma With an Underlying Lymphoma: A Diagnostic Challenge and a Wider Histologic Spectrum Including Adult T-Cell Leukemia/Lymphoma. Appl Immunohistochem Mol Morphol. 2020 Apr;28(4):316-324. (CMBEC-108-004)
  6. Liu CY, Chen BJ, Chuang SS; Taiwan Hematopathology Study Group. Malignant effusions from extranodal NK/T-cell lymphomas are frequently of anaplastic morphology with azurophilic granules and of T-cell lineage. Diagn Cytopathol. 2020 May;48(5):453-463. (CMBEC-108-006)
  7. Chang YT, Chu LJ, Liu YC, Chen CJ, Wu SF, Chen CH, Chang IY, Wang JS, Wu TY, Dash S, Chiang WF, Chiu SF, Gou SB, Chien CY, Chang KP, Yu JS. Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer. Cancers (Basel). 2020 Aug 13;12(8):2273. (CMBEC-103-004)
  8. Huang LY, Hsieh YP, Wang YY, Hwang DY, Jiang SS, Huang WT, Chiang WF, Liu KJ, Huang TT. Single-Cell Analysis of Different Stages of Oral Cancer Carcinogenesis in a Mouse Model. Int J Mol Sci. 2020 Oct 31;21(21):8171. (CMBEC-106-004)
  9. Lee CH, Hung PF, Liu KJ, Chung HL, Yang WC, Hsu KC, Fong TH, Lo HJ, Chen YP, Yang JR, Yen CY. LDOC1 Suppresses Microbe-Induced Production of IL-1β in Human Normal and Cancerous Oral Cells through the PI3K/Akt/GSK-3β Axis. Cancers (Basel). 2020 Oct 27;12(11):3148. (CMBEC-106-009)
  10. Chang WT, Wu NC, Shih JY, Hsu CH, Chen ZC, Cheng BC. Right ventricular reserve post mitral valve repair is associated with heart failure hospitalization. Pulm Circ. 2020 Dec 13;10(4):2045894020943858. (CMBEC-106-005)
  11. Tung HD, Lee PL, Chen JJ, Kuo HT, Sheu MJ, Cheng CT, Chuang TW, Kao HJ, Hou CY, Tsai HH, Wu LC, Lee C. Geographic variation of genotype 6 hepatitis C virus infection in an endemic area of southern Taiwan. J Formos Med Assoc. 2020 Dec;119(12):1876-1880. (CMBEC-107-009)

2021

  1. Lin YW, Chen CY, Shih JY, Cheng BC, Chang CP, Lin MT, Ho CH, Chen ZC, Fisch S, Chang WT. Dapagliflozin Improves Cardiac Hemodynamics and Mitigates Arrhythmogenesis in Mitral Regurgitation-Induced Myocardial Dysfunction. J Am Heart Assoc. 2021 Apr 6;10(7):e019274. (CMBEC-106-005)
  2. Chang ST, Chen SW, Chen BJ, Pan ST, Karube K, Chuang SS. Aberrant TTF-1 Expression in Peripheral T-Cell Lymphomas: A Diagnostic Pitfall. Int J Surg Pathol. 2021 Apr;29(2):165-168. (CMBEC-107-007)
  3. Chen CW, Yang CH, Lin YH, Hou YC, Cheng TJ, Chang ST, Huang YH, Chung ST, Chio CC, Shan YS, Cheng HC, Chang WT. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway. Int J Mol Sci. 2021 Apr 6;22(7):3782. (CMBEC-107-013)
  4. Tung HD, Lee PL, Chen JJ, Kuo HT, Sheu MJ, Cheng CT, Chuang TW, Kao HJ, Wu YH, Pang MG, Lin CH, Hou CY, Tsai HH, Wu LC, Lee C. Hepatitis C Virus Subtypes Novel 6g-Related Subtype and 6w Could Be Indigenous in Southern Taiwan with Characteristic Geographic Distribution. Viruses. 2021 Jul 7;13(7):1316. (CMBEC-107-009)
  5. Wu YH, Huang YF, Chang TH, Chen CC, Wu PY, Huang SC, Chou CY. COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells. Oncogene. 2021 Jul;40(26):4503-4519. (CMBEC-108-009)
  6. Chen JW, Wu JH, Chiang WF, Chen YL, Wu WS, Wu LW. Taxonomic and Functional Dysregulation in Salivary Microbiomes During Oral Carcinogenesis. Front Cell Infect Microbiol. 2021 Sep 16;11:663068. (CMBEC-107-005)
  7. Yu WH, Li CH, Wang RC, Yeh CY, Chuang SS. Machine Learning Based on Morphological Features Enables Classification of Primary Intestinal T-Cell Lymphomas. Cancers (Basel). 2021 Oct 30;13(21):5463. (CMBEC-107-006)
  8. Hong CM, Lin YY, Liu CJ, Lai YY, Yeh SH, Yang HC, Kao JH, Hsu SJ, Huang YH, Yang SS, Kuo HT, Cheng PN, Yu ML, Chen PJ. Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan. Viruses. 2021 Nov 17;13(11):2294. (CMBEC-109-002)
  9. Wu YH, Huang YF, Chang TH, Wu PY, Hsieh TY, Hsiao SY, Huang SC, Chou CY. miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1. Cancers (Basel). 2021 Dec 13;13(24):6257. (CMBEC-108-009)

2022

  1. Chen BJ, Wang RC, Jhuang JY, Chen SW, Su YZ, Tseng CE, Chiang CT, Wu YT, Chuang SS. Primary cutaneous gamma/delta T-cell lymphoma in Taiwan: A series of six cases with frequent solitary presentation and relatively indolent behavior. J Cutan Pathol. 2022 Apr;49(4):350-357. (CMBEC-110-002)
  2. Chuang WY, Yu WH, Lee YC, Zhang QY, Chang H, Shih LY, Yeh CJ, Lin SM, Chang SH, Ueng SH, Wang TH, Hsueh C, Kuo CF, Chuang SS, Yeh CY. Deep Learning-Based Nuclear Morphometry Reveals an Independent Prognostic Factor in Mantle Cell Lymphoma. Am J Pathol. 2022 Dec;192(12):1763-1778. (CMBEC-107-003)

2023

  1. Wu MH, Chang CT, Lin YN, Chen CJ. Identification of a potential prognostic plasma biomarker of acute ischemic stroke via untargeted LC-MS metabolomics. Proteomics Clin Appl. 2023 Jun 27:e2200081. (CMBEC-109-005)
  2. Hsu XR, Wu JE, Wu YY, Hsiao SY, Liang JL, Wu YJ, Tung CH, Huang MF, Lin MS, Yang PC, Chen YL, Hong TM. Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer. J Exp Clin Cancer Res. 2023 Oct 26;42(1):283. (CMBEC-110-003)

2024

  1. Chen BJ, Hsieh TH, Yuan CT, Wang RC, Yang CF, Chuang WY, Su YZ, Ho CH, Lin CH, Chuang SS. Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan. Pathol Res Pract. 2024 Jan;253:155059. (CMBEC-108-001)
  2. Hsu YC, Tsai MH, Wu G, Liu CL, Chang YC, Lam HB, Su PY, Lung CF, Yang PS. Role of Epstein-Barr Virus in Breast Cancer: Correlation with Clinical Outcome and Survival Analysis. J Cancer. 2024 Mar 4;15(8):2403-2411. (CMBEC-109-013)